Ramzi Ajjan
-
- Diabetes Management and Research 70
- Diabetes Treatment and Management 48
- Diabetes, Cardiovascular Risks, and Lipoproteins 21
- Thyroid Disorders and Treatments 17
- Internal Medicine top 1%
-
- Antiplatelet Therapy and Cardiovascular Diseases 25
- Hematology top 2%
- Genetics top 1%
- Diabetes and associated disorders 33
-
- Blood properties and coagulation 40
-
- Pancreatic function and diabetes 31
- Co-authors
- Anthony P. WeetmanPeter J. GrantGerry RaymanJean‐Pierre RivelineH. HanaireNorbert HermannsThomas HaakP. F. Watson
- Cited by
- Endocrinology, Diabetes and MetabolismInternal MedicineCardiology and Cardiovascular Medicine
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (2 papers)Circulation (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Ramzi Ajjan
220 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Endocrinology, Diabetes and Metabolism 3.4k
- Internal Medicine 371
- Cardiology and Cardiovascular Medicine 1.4k
- Hematology 578
- Genetics 1.4k
Countries citing papers authored by Ramzi Ajjan
This map shows the geographic impact of Ramzi Ajjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramzi Ajjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramzi Ajjan more than expected).
Fields of papers citing papers by Ramzi Ajjan
This network shows the impact of papers produced by Ramzi Ajjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramzi Ajjan. The network helps show where Ramzi Ajjan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ramzi Ajjan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 41 | |
| 6 | Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomised controlled trial | 2022 | 15 |
| 7 | 2022 | 40 | |
| 8 | 2022 | 14 | |
| 9 | 2021 | 21 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 25 | |
| 12 | 2020 | 2 | |
| 13 | 2019 | 71 | |
| 14 | 2019 | 12 | |
| 15 | 2017 | 70 | |
| 16 | 2017 | 35 | |
| 17 | 2017 | 27 | |
| 18 | 2013 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 1998 | 67 |
About Ramzi Ajjan
Ramzi Ajjan is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine and Hematology, having authored 232 papers that have together received 7.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (70 papers), Diabetes Treatment and Management (48 papers), Blood properties and coagulation (40 papers), Diabetes and associated disorders (33 papers), Pancreatic function and diabetes (31 papers), Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers) and Thyroid Disorders and Treatments (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Internal Medicine (371 citations) and Cardiology and Cardiovascular Medicine (1.4k citations). Ramzi Ajjan has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony P. Weetman, Peter J. Grant, Gerry Rayman, Jean‐Pierre Riveline, H. Hanaire, Norbert Hermanns, Thomas Haak, P. F. Watson, Robert F. Storey and Timothy C. Dunn. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.